MethyLPREDNISolone Acetate Injectable Suspension, USP, 400 mg/10 mL (40 mg/mL), 10 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA, NDC 16714-090-01
Recall Number: D-1063-2022
Firm: Mckesson Medical-Surgical Inc. Corporate Office
Classification: Class II
Status: Terminated
Report Date: 20220615
Initiation Date: 20220413
Termination Date: 20231130
Reason for Recall
cGMP deviations: Temperature abuse
Product Description
MethyLPREDNISolone Acetate Injectable Suspension, USP, 400 mg/10 mL (40 mg/mL), 10 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA, NDC 16714-090-01